Utility of pleural fluid for predictive marker testing in malignant pleural effusion
J. Ferguson (Glasgow, United Kingdom), C. Craig (Manchester, United Kingdom), V. Randles (Cheshire, United Kingdom), T. Taylor (Cheshire, United Kingdom), L. Brown (Manchester, United Kingdom), D. Fullerton (Cheshire, United Kingdom), M. Evison (Manchester, United Kingdom), K. Blyth (Glasgow, United Kingdom), S. Tsim (Glasgow, United Kingdom)
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Ferguson (Glasgow, United Kingdom), C. Craig (Manchester, United Kingdom), V. Randles (Cheshire, United Kingdom), T. Taylor (Cheshire, United Kingdom), L. Brown (Manchester, United Kingdom), D. Fullerton (Cheshire, United Kingdom), M. Evison (Manchester, United Kingdom), K. Blyth (Glasgow, United Kingdom), S. Tsim (Glasgow, United Kingdom). Utility of pleural fluid for predictive marker testing in malignant pleural effusion. 4493
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006
Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid Source: Eur Respir J 2006; 28: Suppl. 50, 455s Year: 2006
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Utility of closed pleural biopsy in the diagnosis of pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006
Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012
Utility of pleural fluid glucose measurement in TB pleural effusions. Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020
The Abrams pleural biopsy is still useful in the diagnosis of pleural effusions Source: Annual Congress 2009 - Pleural diseases Year: 2009
Diagnostic approach in a patient with pleural effusion Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131 Year: 2002
Evaluation of pleural fluid clot histology in the diagnosis of pleural malignancy Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
Diagnostic usefulness of tumour markers in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Combined pleural CRP and chest ultrosonography for discrimination between tuberculous and malignant pleural effusion Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005
Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008
Value of pleural puncture in pleural effusions Source: School Course 2014 - Medical Thoracoscopy Year: 2014
Prognostic features of residual pleural thickening after parapneumonic pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 605s Year: 2002
Closed pleural needle biopsy and pleural fluid examination in pathological diagnosis of malignant pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
The value of biochemical parameters of the pleural aspirate in predicting success of chemical pleurodesis in malignant pleural effusion Source: Annual Congress 2010 - Oncological problems, surgical risk and complications Year: 2010
Pleural fluid leptin level for the differential diagnosis of pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010